Form 10-Q VERTEX PHARMACEUTICALS For: Jun 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Vertex (VRTX) PT Raised to $576 at Wolfe Research
August 5, 2024 5:19 AM EDTWolfe Research analyst Andy Chen raised the price target on Vertex (NASDAQ: VRTX) to $576.00 (from $520.00) while maintaining a Outperform rating.
The analyst comments "Revenue & earnings in-line. Now what after the bull run? Little incremental news aside from two exhibits on T1D. Our... More
